Value of Comorbidity Scales for Predicting Survival After Radiochemotherapy of Small Cell Lung Cancer

Lukas Kaesmann, Stefan Janssen, Steven E. Schild, Dirk Rades

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The Charlson Comorbidity Index plus three comorbidity scales were evaluated for survival after radiochemotherapy of limited stage SCLC. For the Charlson Comorbidity Index, 2–4 points were compared to 5–8 points. For the Age-Comorbidity Score, 2–6 points were compared to 7–10 points. For the Medical Research Council (MRC) Breathlessness Scale, grades 0–2 were compared to grades 3–5. For the Simplified Comorbidity Score, 0–5 points were compared to 6–11 and 12–17 points. Charlson Comorbidity Index (p = 0.022) and MRC Breathlessness Scale (p 

Original languageEnglish (US)
Pages (from-to)295-298
Number of pages4
JournalLung
Volume194
Issue number2
DOIs
StatePublished - Apr 1 2016

Fingerprint

Small Cell Lung Carcinoma
Chemoradiotherapy
Comorbidity
Dyspnea
Biomedical Research

Keywords

  • Charlson Comorbidity Index
  • MRC Breathlessness Scale
  • Radiochemotherapy
  • Small cell lung cancer
  • Survival prognosis

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Value of Comorbidity Scales for Predicting Survival After Radiochemotherapy of Small Cell Lung Cancer. / Kaesmann, Lukas; Janssen, Stefan; Schild, Steven E.; Rades, Dirk.

In: Lung, Vol. 194, No. 2, 01.04.2016, p. 295-298.

Research output: Contribution to journalArticle

Kaesmann, Lukas ; Janssen, Stefan ; Schild, Steven E. ; Rades, Dirk. / Value of Comorbidity Scales for Predicting Survival After Radiochemotherapy of Small Cell Lung Cancer. In: Lung. 2016 ; Vol. 194, No. 2. pp. 295-298.
@article{7473423258a748ec916060289cb30a7a,
title = "Value of Comorbidity Scales for Predicting Survival After Radiochemotherapy of Small Cell Lung Cancer",
abstract = "The Charlson Comorbidity Index plus three comorbidity scales were evaluated for survival after radiochemotherapy of limited stage SCLC. For the Charlson Comorbidity Index, 2–4 points were compared to 5–8 points. For the Age-Comorbidity Score, 2–6 points were compared to 7–10 points. For the Medical Research Council (MRC) Breathlessness Scale, grades 0–2 were compared to grades 3–5. For the Simplified Comorbidity Score, 0–5 points were compared to 6–11 and 12–17 points. Charlson Comorbidity Index (p = 0.022) and MRC Breathlessness Scale (p ",
keywords = "Charlson Comorbidity Index, MRC Breathlessness Scale, Radiochemotherapy, Small cell lung cancer, Survival prognosis",
author = "Lukas Kaesmann and Stefan Janssen and Schild, {Steven E.} and Dirk Rades",
year = "2016",
month = "4",
day = "1",
doi = "10.1007/s00408-016-9857-4",
language = "English (US)",
volume = "194",
pages = "295--298",
journal = "Lung",
issn = "0341-2040",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Value of Comorbidity Scales for Predicting Survival After Radiochemotherapy of Small Cell Lung Cancer

AU - Kaesmann, Lukas

AU - Janssen, Stefan

AU - Schild, Steven E.

AU - Rades, Dirk

PY - 2016/4/1

Y1 - 2016/4/1

N2 - The Charlson Comorbidity Index plus three comorbidity scales were evaluated for survival after radiochemotherapy of limited stage SCLC. For the Charlson Comorbidity Index, 2–4 points were compared to 5–8 points. For the Age-Comorbidity Score, 2–6 points were compared to 7–10 points. For the Medical Research Council (MRC) Breathlessness Scale, grades 0–2 were compared to grades 3–5. For the Simplified Comorbidity Score, 0–5 points were compared to 6–11 and 12–17 points. Charlson Comorbidity Index (p = 0.022) and MRC Breathlessness Scale (p 

AB - The Charlson Comorbidity Index plus three comorbidity scales were evaluated for survival after radiochemotherapy of limited stage SCLC. For the Charlson Comorbidity Index, 2–4 points were compared to 5–8 points. For the Age-Comorbidity Score, 2–6 points were compared to 7–10 points. For the Medical Research Council (MRC) Breathlessness Scale, grades 0–2 were compared to grades 3–5. For the Simplified Comorbidity Score, 0–5 points were compared to 6–11 and 12–17 points. Charlson Comorbidity Index (p = 0.022) and MRC Breathlessness Scale (p 

KW - Charlson Comorbidity Index

KW - MRC Breathlessness Scale

KW - Radiochemotherapy

KW - Small cell lung cancer

KW - Survival prognosis

UR - http://www.scopus.com/inward/record.url?scp=84961199804&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961199804&partnerID=8YFLogxK

U2 - 10.1007/s00408-016-9857-4

DO - 10.1007/s00408-016-9857-4

M3 - Article

C2 - 26883133

AN - SCOPUS:84961199804

VL - 194

SP - 295

EP - 298

JO - Lung

JF - Lung

SN - 0341-2040

IS - 2

ER -